Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab. (Q47351455)

From Wikidata
Jump to navigation Jump to search
scientific article published in June 2004
edit
Language Label Description Also known as
English
Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab.
scientific article published in June 2004

    Statements

    Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit